cp wire

CP Wire Articles

Biomica Initiates Microbiome Based Immuno-Oncology Studies

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ:  EVGN) (TASE: EVGN), announced on 4/17/19 the... read more

Wed, 04/17/19 - 09:44 am
Flagship Pioneering Unveils Microbiome Focused Kintai Therapeutics

 On 4/16/19, Flagship Pioneering,  unveiled Kintai Therapeutics and named Paul-Peter Tak, M.D., Ph.D., as president, chief executive officer, and member of the board of directors. Kintai is... read more

Tue, 04/16/19 - 09:54 am
Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO

Cortexyme has filed for an $86 million IPO. The company is developing treatments for neurodegenerative diseases based on the discovery of pathogenic bacteria in the brains of Alzheimer's patients... read more

Mon, 04/15/19 - 09:56 am
Microbiome Report for Week Ending 4/6/19

C3J Therapeutics Receives Patent Covering Synthetic... read more

Fri, 04/12/19 - 09:52 am
Axcella Health Files for $86 Million IPO

Early stage biotech, Axcella Health, has filed for an $86 million IPO. The initial filing documents do not provide the number of shares in the offering or the expected price range. The company has... read more

Fri, 04/12/19 - 09:46 am

Pages